AMGN Technical Analysis

As of date:	3/26/2020
AMGN stock price:	198.49
AMGN 50 DMA:	215.03
AMGN 200 DMA:	205.97
AMGN MACD (200-50):	-9.06
AMGN RSI:	45.96

Extremely Overbought
	45.96
Extremely Oversold

Also see:
AMGN Market Cap History
AMGN Shares Outstanding History
AMGN YTD Return

Quotes delayed 20 minutes

Get Free SEC filing alerts for AMGN:
AMGN SEC Filing Email Alerts Service

COUP Makes Bullish Cross Above Critical Moving Average
1 hour, 25 minutes ago

Bullish Two Hundred Day Moving Average Cross - IVC
1 hour, 40 minutes ago

International Seaways Breaks Above 200-Day Moving Average - Bullish for INSW
1 hour, 40 minutes ago

AA Stock Crowded With Sellers
6 hours, 15 minutes ago

CADIZ Shares Cross Above 200 DMA
6 hours, 20 minutes ago

Noble Energy Stock Getting Very Oversold
6 hours, 25 minutes ago

Shares of WHD Now Oversold
6 hours, 25 minutes ago

Shares of FTI Now Oversold
6 hours, 25 minutes ago

Calithera Biosciences (CALA) Shares Cross Above 200 DMA
6 hours, 25 minutes ago

OMI Crosses Below Key Moving Average Level
6 hours, 36 minutes ago

Shares of SVXY Now Oversold
6 hours, 46 minutes ago

Daily Small Cap Bull 3X Shares (TNA) Enters Oversold Territory
6 hours, 46 minutes ago

MLPA Crowded With Sellers
6 hours, 46 minutes ago

Denali Therapeutics (DNLI) Shares Cross Above 200 DMA
Thursday, March 26, 4:36 PM

Anglogold Ashanti (AULGF) Shares Cross Above 200 DMA
Thursday, March 26, 4:23 PM

More Technical Analysis News

Amgen is a biotechnology company that discovers, develops, manufactures and delivers human therapeutics. Co.'s products include: Enbrel® (etanercept), which is used in indications for the treatment of adult patients with moderately to severely active rheumatoid arthritis, patients with chronic moderate-to-severe plaque psoriasis who are candidates for systemic therapy or phototherapy and patients with active psoriatic arthritis; and Prolia® (denosumab), which is used for the treatment of postmenopausal women with osteoporosis at high risk of fracture or multiple risk factors for fracture, or patients who have failed or are intolerant to other available osteoporosis therapy.

When researching a stock like Amgen, many investors are the most familiar with Fundamental Analysis — looking at a company's balance sheet, earnings, revenues, and what's happening in that company's underlying business. Investors who use Fundamental Analysis to identify good stocks to buy or sell can also benefit from AMGN Technical Analysis to help find a good entry or exit point. Technical Analysis is blind to the fundamentals and looks only at the trading data for AMGN stock — the real life supply and demand for the stock over time — and examines that data in different ways.

10 Most Oversold S&P 500 Stocks

10 Most Overbought S&P 500 Stocks

10 ETFs With Stocks Insiders Are Buying

10 ETFs With Most Upside To Targets

The DividendRank Top 25

Warren Buffett Dividend Stocks

10 Cheap Dividend Stocks Under $10

10 Top DividendRank'ed Energy Stocks

The 10 Highest Yielding Preferred Stocks

The 15 Most Active S&P Call & Put Options

Video: Technical Analysis

If the video does not load after a few moments, Upgrade to the Latest Flash Player.

Amgen (AMGN) is categorized under the Healthcare sector; to help you further research Technical Analysis, below are some other companies in the same sector:

BAX Technical Analysis
BDX Technical Analysis
BIIB Technical Analysis
BMY Technical Analysis
BSX Technical Analysis
CAH Technical Analysis
CELG Technical Analysis
CNC Technical Analysis
COO Technical Analysis
DGX Technical Analysis
More Healthcare companies »

Nothing in TechnicalAnalysisChannel.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.

AMGN Technical Analysis | www.TechnicalAnalysisChannel.com | Copyright © 2019 - 2020, All Rights Reserved